M

Malcolm J. Moore

University Health Network

ORCID: 0009-0007-7493-3558

Publishes on Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies. 558 papers and 75.1k citations.

PubIndex Score98Top 2% · seniorHow it's scored

558Publications

75.1kTotal Citations

First publication: 1982First senior author: 1988

Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Cancer Treatment and Pharmacology Lung Cancer Treatments and Mutations

Top publicationsby citations

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Markus F. Renschler, Thomas J. Ervin et al.|New England Journal of Medicine|2013

Cited by 6.6k

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Daniel D. Von Hoff, Malcolm J. Moore et al.|Journal of Clinical Oncology|1997

Cited by 5.9k

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, Wendy R. Parulekar, David Goldstein et al.|Journal of Clinical Oncology|2007

Cited by 3.9k

<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

Christos S. Karapetis, John Zalcberg, Dongsheng Tu et al.|New England Journal of Medicine|2008

Cited by 3.6k

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Leonard B. Saltz, Langdon L. Miller, John V. Cox et al.|New England Journal of Medicine|2000

Cited by 3k